pcos treatment glp-1 The dual impact of receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials Before you start GLP-1 for

When I first started recommending GLP-1 agonists for weight loss back in 2016 and 2017 there was some small evidence that they were associated with thyroid cancer

7 Nutritional deficiencies, commonly observed in states of malnutrition or restrictive intake, deprive the skeleton of essential substrates for bone formation and maintenance

There is also evidence that patients may regain weight after they stop treatment

Understanding this difference is important because GLP-1 therapy is not a trend, a cosmetic injection, or a one-size-fits-all solution

The caveat is that semaglutide 1 mg is not the highest available dose

Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus